mots-c dosage protocol: Frequently asked questions

No. Administer the standard dose on your next scheduled day and continue the weekly protocol. MOTS-c's short half-life (4–6 hours) means missing one dose does not create a deficit that requires compensation. Doubling the dose does not produce proportional benefit because AMPK activation reaches saturation. Excess peptide is cleared without additional metabolic effect. If you miss a dose by fewer than three days, you can administer it as soon as you remember and resume the weekly schedule from that point.

The peptide has likely degraded. While limited data exist on room-temperature stability for reconstituted MOTS-c specifically, related mitochondrial peptides lose 30–50% potency after 24 hours at 20–25°C. Because peptide degradation is irreversible, continuing to use the vial risks administering subtherapeutic doses that produce no measurable research outcome. If the vial was at room temperature for fewer than six hours, it may retain partial activity, but this introduces variability into the protocol. For research-grade applications, discard and reconstitute a fresh vial to ensure consistency.

Discard the vial immediately. Cloudiness indicates peptide aggregation or microbial contamination, both of which render the solution unusable. Aggregated peptides lose bioactivity and can trigger immune responses if administered. Contaminated solutions introduce infection risk. Cloudiness is often caused by injecting bacteriostatic water too forcefully onto the lyophilized powder, creating mechanical shear that denatures the peptide structure. To prevent this, always inject the water slowly down the vial wall and swirl gently rather than shaking.

Maintain the same circadian timepoint for all doses throughout the study period. MOTS-c's metabolic effects interact with circadian-regulated glucose metabolism and insulin sensitivity rhythms. Dosing at 9 AM one day and 5 PM the next introduces uncontrolled variability. If scheduling conflicts arise, shift the entire cohort to the new timepoint consistently rather than varying administration times within subjects. Circadian misalignment contributes more noise to metabolic endpoints than small variations in absolute dose.

Verify peptide integrity first. Request HPLC or mass spectrometry analysis from your supplier to confirm the amino acid sequence matches MOTS-c and purity exceeds 95%. If peptide quality is confirmed, review your reconstitution and storage logs for temperature deviations, then verify your dosing calculations account for body surface area scaling if you've changed model organisms. The most common replication failure in our reviews traces to using mouse-published doses in rat models without adjusting for the 6.2× body surface area conversion factor. A 5mg/kg mouse dose becomes approximately 0.8mg/kg in rats, not 5mg/kg.

Discard the vial and reconstitute a fresh aliquot. Even 12 hours at room temperature (20–25°C) significantly accelerates oxidative degradation of the methionine and tryptophan residues essential for biological activity. While the solution may appear unchanged, the peptide's capacity for nuclear translocation and AMPK activation drops measurably. Published stability data for similar mitochondrial peptides shows 30–40% activity loss after 24 hours at room temperature. Refrigeration at 2–8°C is non-negotiable for maintaining peptide integrity throughout the 28-day use window.

Yellowing indicates oxidative degradation has already occurred during storage or shipping. Do not reconstitute or use. Intact lyophilized MOTS-c should be white to off-white. Yellow or amber discoloration suggests the peptide was exposed to temperature excursions above −20°C or prolonged light exposure before reaching your lab. Contact your supplier for replacement and verify their cold chain shipping procedures include temperature-logging devices. Oxidized peptide in powder form will not regain activity upon reconstitution.